Dnb Oaimetadata only
Susceptibility of clinical isolates, laboratory-adapted and drug-resistant herpes simplex virus strains to helicase-primase inhibitor adibelivir (IM-250) and its synergy in combination therapy with acyclovir, penciclovir and foscarnet
610 medizin, gesundheit
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 619770
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.